---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-084291"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:45:12.747543+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics regains Nasdaq compliance; subject to one-year monitoring period

## Summary
- Nasdaq Hearings Panel found Company regained compliance with all continued listing rules on Feb 26, 2026.
- Company demonstrated compliance with Equity Rule by Dec 31, 2025 and other rules by Feb 16, 2026.
- Company subject to Mandatory Panel Monitor for one year; immediate delisting if Equity Rule violated again.
- If non-compliant during monitor, Staff will issue Delist Determination Letter; Company can request new hearing.

## SEC filing metadata
- accession: 0001193125-26-084291
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000119312526084291/0001193125-26-084291-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000119312526084291/hcwb-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-084291
- JSON: https://secwatch.observer/filing/0001193125-26-084291.json
- Plain text: https://secwatch.observer/filing/0001193125-26-084291.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.